212 related articles for article (PubMed ID: 17902124)
21. Foscarnet treatment in various cytomegalovirus infections.
Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
[No Abstract] [Full Text] [Related]
23. Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
Holida MD; Trigg ME; Rumelhart SL; Lee NF; Kook H; Peters C
AIDS; 1995 May; 9(5):531-2. PubMed ID: 7639984
[No Abstract] [Full Text] [Related]
24. A Case Report of Successful Use of Twice-Daily Letermovir in the Treatment of Resistant Cytomegalovirus in a Small Bowel Transplant Recipient.
Joharji H; Alaidaros F; Koujan H; Hamad A; Almaghrabi RS; Zidan A; Broering D; Al-Jedai A
Transplant Proc; 2022; 54(6):1679-1681. PubMed ID: 35842318
[TBL] [Abstract][Full Text] [Related]
25. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host.
Leman JS; Toalson TW; Wlodaver CG
J Okla State Med Assoc; 1997; 90(7):367-9. PubMed ID: 9379249
[TBL] [Abstract][Full Text] [Related]
26. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
Rosen HR; Benner KG; Flora KD; Rabkin JM; Orloff SL; Olyaei A; Chou S
Transplantation; 1997 Feb; 63(3):476-8. PubMed ID: 9039944
[No Abstract] [Full Text] [Related]
27. [A case of successful treatment with ganciclovir for cytomegalovirus pneumonia after pulmonary lobectomy].
Inaba H; Ohta S; Nishimura T; Takamochi K; Ishida I; Etoh T; Honda A; Nakajima H; Muro H; Nagashima Y
Kyobu Geka; 1997 Nov; 50(12):1004-8. PubMed ID: 9388344
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods.
Macartney M; Gane EJ; Portmann B; Williams R
Transplantation; 1997 Jun; 63(12):1803-7. PubMed ID: 9210508
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
Akesson-Johansson A; Lernestedt JO; Ringdén O; Lönnqvist B; Wahren B
Bone Marrow Transplant; 1986 Dec; 1(2):215-20. PubMed ID: 2844334
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
[No Abstract] [Full Text] [Related]
31. [Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation].
Ma R; He Y; Xu LP; Zhang XH; Wang Y; Liu KY; Huang XJ; Sun YQ
Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):76-83. PubMed ID: 36631041
[No Abstract] [Full Text] [Related]
32. [Progress in the management of cytomegalovirus(CMV) infection].
Tanaka N; Kimura H; Morishima T
Nihon Rinsho; 1998 Jan; 56(1):167-72. PubMed ID: 9465684
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus disease after liver transplantation: diagnostics and therapy.
Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108
[No Abstract] [Full Text] [Related]
34. [Interstitial pulmonitis due to the cytomegalovirus in an immunocompetent adolescent: treatment with ganciclovir].
Pellegrini G; Collo G; Barbi M; Binda A; Masarone M
Pediatr Med Chir; 1996; 18(3):315-7. PubMed ID: 8966135
[TBL] [Abstract][Full Text] [Related]
35. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease.
Boivin G; Chou S; Quirk MR; Erice A; Jordan MC
J Infect Dis; 1996 Mar; 173(3):523-8. PubMed ID: 8627012
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment.
Craigen JL; Grundy JE
Transplantation; 1996 Oct; 62(8):1102-8. PubMed ID: 8900310
[TBL] [Abstract][Full Text] [Related]
37. Use of ganciclovir in the treatment of cytomegalovirus infections.
Henderson JR
Br J Clin Pract; 1989 Jul; 43(7):233-7. PubMed ID: 2557071
[TBL] [Abstract][Full Text] [Related]
38. Resistance of human cytomegalovirus to antiviral drugs.
Erice A
Clin Microbiol Rev; 1999 Apr; 12(2):286-97. PubMed ID: 10194460
[TBL] [Abstract][Full Text] [Related]
39. Combination antiviral therapy for cytomegalovirus disease in patients with AIDS.
Cline JJ; Garrett AD
Ann Pharmacother; 1997 Sep; 31(9):1080-2. PubMed ID: 9296250
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.
Wilcox CM; Straub RF; Schwartz DA
Am J Med; 1995 Feb; 98(2):169-76. PubMed ID: 7847433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
